“The pharmaceutical industry needs to understand how internally widespread their approach needs to change to permanently alter recruitment in clinical trials,” Whitlow says. “They need changes to happen from the time they think and plan a trial to post-marketing of who is the drug going to and who knows about it.
https://www.birminghammedicalnews.com/article/8374/adding-color-to-clinical-studies
